# A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight

> **NCT07004322** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Obesity

## Interventions

- **DRUG:** NNC0519-0130
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07004322
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-26
- **Primary completion:** 2026-01-28
- **Final completion:** 2026-01-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07004322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07004322, "A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07004322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*